Pharming Group N.V. Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 83.59%87.37%88.91%89.37%91.46%89.72%88.09%
EBT Margin 0.63%27.62%20.78%0.01%8.87%-1.87%-2.90%
EBIT Margin 28.12%36.03%35.94%6.82%8.87%-2.20%-2.90%
EBITDA Margin 28.12%36.03%35.94%6.82%8.87%-2.20%-2.90%
Operating Margin 28.12%36.03%35.94%6.82%8.87%-2.20%-2.90%
Net Margin 18.50%21.41%9.58%-3.55%8.23%-4.44%-4.03%
FCF Margin 28.13%37.75%37.22%-5.40%-0.67%-0.59%-0.27%
Efficiency
Inventory Average 7.56M7.79M-1.55M-2.21M27.41M56.26M
Assets Average 128.15M198.85M411.56M444.33M431.42M
Equity Average 58.78M96.54M198.78M211.71M219.92M
Invested Capital 0.27M117.69M0.34M193.09M204.64M218.78M221.06M
Asset Utilization Ratio 1.661.000.500.550.69
Leverage & Solvency
Debt to Equity 0.34147.820.00
Debt Ratio 0.1564.800.00
Equity Ratio 0.460.440.490.480.470.55
Valuation
Enterprise Value -94.87M-76.89M763.44M570.09M774.05M751.91M681.26M
Market Capitalization 969.53M571.11M775.15M753.44M682.76M
Return Ratios
Return on Sales 0.18%0.21%0.18%-0.04%0.08%-0.01%-0.04%
Return on Capital Employed 1.49%0.09%0.05%-0.01%-0.02%
Return on Invested Capital 0.90%1.11%0.09%-0.02%
Return on Assets 0.29%-0.04%0.04%-0.01%-0.03%
Return on Equity 0.64%-0.07%0.09%-0.01%-0.05%